title: Individual differences in stress-induced dopamine release in the nucleus accumbens are influenced by corticosterone.
abstract: Stressful experiences, glucocorticoids hormones and dopaminergic neurons seems to interact in determining a higher propensity to develop drug abuse. In this report, we studied the acute interaction between these three factors. For this purpose, we compared stress-induced dopamine release in intact rats and in rats in which stress-induced corticosterone secretion was experimentally blocked. Ten-minute tail-pinch was used as a stressor and dopamine release estimated in the nucleus accumbens by using the microdialysis technique. Individual differences were also taken into account by comparing rats identified as either predisposed (HRs) or resistant (LRs) to develop self-administration of drugs of abuse, on the basis of their locomotor response to novelty. It was found that suppression of stress-induced corticosterone secretion significantly decreased stress-induced dopamine release. However, such an effect greatly differed between HR and LR rats. When corticosterone secretion was intact HR animals had a higher and longer dopamine release in response to stress than LRs. The blockade of stress-induced corticosterone secretion selectively reduced the dopaminergic response of HRs that did not differ from LRs anymore. These findings strength the idea that glucocorticoids could be involved in determining propensity to develop drug self-administration. In particular, these hormones could play a role in determining the higher dopaminergic activity that characterizes drug proned individuals.
authors.affiliation: Laboratoire de Psychobiologie des Comportements Adaptatifs, Domaine de Carreire, Bordeaux, France.
authors.forename: F
authors.initials: F
authors.lastname: Rougé-Pont
authors.forename: V
authors.initials: V
authors.lastname: Deroche
authors.forename: M
authors.initials: M
authors.lastname: Le Moal
authors.forename: P V
authors.initials: PV
authors.lastname: Piazza
mesh_terms: D000315:Adrenalectomy; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology; D001923:Brain Chemistry / Q000187:drug effects / Q000502:physiology; D003345:Corticosterone / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology*; D004298:Dopamine / Q000378:metabolism*; D008297:Male; D017551:Microdialysis; D009714:Nucleus Accumbens / Q000378:metabolism*; D010146:Pain / Q000378:metabolism; D010812:Physical Stimulation; D051381:Rats; D017207:Rats, Sprague-Dawley; D013312:Stress, Physiological / Q000378:metabolism*
chemical_list: D000893:Anti-Inflammatory Agents; D004298:Dopamine; D003345:Corticosterone